NAB001

· Promius Pharma, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NAB001, covering 2013-07-11 to 2013-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails [Phase 3]